Accelrys Continues to Expand Breadth of Product Offerings Optimized For IBM Servers
Wide Range of Accelrys Life Sciences Informatics Applications Now Available On
IBM Systems, Including RS3 - Leading Oracle-Based Cheminformatics Database
SAN DIEGO, April 8 /PRNewswire-FirstCall/ -- Accelrys Inc. today announced the commercial availability of five additional Accelrys software applications on IBM eServer* pSeries* systems running AIX*. This is the second group of product releases resulting from the global strategic alliance between IBM and Accelrys that was announced in January of this year. The alliance seeks to enhance drug research and development (R&D) operations by creating a collaborative information technology environment to help chemists and biologists develop new drugs faster, more efficiently, and at lower costs. "This new milestone reflects the commitment and aggressive timetable IBM and Accelrys have set to deliver innovative information technologies through our alliance," said Mike Svinte, vice president of Worldwide Business Development, IBM Life Sciences. "We have now enabled ten of Accelrys' leading life sciences applications to run optimally on IBM's servers, and more applications are in the pipeline. This is good news for customers who need powerful solutions to improve the efficiency of their pharmaceutical R&D operations." The second set of Accelrys applications optimized to run on IBM eServer pSeries systems, including the new p690 server code named "Regatta," are RS3, CNX, and HypoGen, HipHop, and Confirm from the Catalyst(R) suite. These additional applications broaden Accelrys' suite of IBM ported applications to a total of ten diversified products with functionalities supporting bioinformatics, cheminformatics, modeling, and analytics. Over the next three quarters of 2002, Accelrys will continue to collaborate with IBM to migrate and optimize the majority of its top life sciences applications on IBM systems. "We recognize that innovation and efficiency are critical to drug discovery and development and are very pleased to offer an expanded group of Accelrys products on the IBM eServer pSeries ahead of schedule," said Dr. Scott Kahn, general manager and senior vice president of Life Science for Accelrys. "Our successful alliance with IBM and our aggressive timetable enable us to stay a step ahead of our customers' needs and expectations." Products ported to the IBM platform will initially operate on AIX servers and will be designed to seamlessly integrate into the upcoming Discovery Studio(TM) enterprise client-server environment. In addition, Accelrys products that are Discovery Studio enabled will be available on a range of server environments, including AIX and other proprietary versions of UNIX(TM) as well as Windows NT and Linux. The product roadmaps have been specifically designed and licensed to facilitate the transition from an isolated workstation environment to a collaborative enterprise computing model, recognizing the need to maintain data integrity, full application access and the ability to scale and deploy high-performance compute resources dynamically. About Accelrys Inc. Accelrys is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists, and materials scientists for product design, drug discovery, and development. Accelrys' platform technology and consulting services enable enterprise-wide solutions tailored to today's leading research organizations. The company's three main centers of excellence are in San Diego, CA, Princeton, NJ, and Cambridge, UK. These centers combine research and product development with facilities to support significant collaborative projects. Accelrys is a subsidiary of Pharmacopeia, Inc. (Nasdaq: PCOP) and was launched in June 2001, combining leading software companies Molecular Simulations Inc., Synopsys Scientific Systems, Oxford Molecular, GCG, and Synomics Ltd. More information on Accelrys can be found at http://www.accelrys.com. Catalyst is a registered trademark of Accelrys Inc. within the United States and/or various other countries. Discovery Studio is a trademark of Accelrys Inc. within the United States and/or various other countries. * Indicates trademark or registered trademark of IBM Corporation. eServer, pSeries and AIX are registered trademarks of IBM Corporation. UNIX is a registered trademark in the United States and other countries licensed exclusively through The Open Group. CONTACT: Jim Rivas of Accelrys, +1-858-799-5393, or firstname.lastname@example.org MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X34688659
SOURCE Accelrys, Inc.
More by this Source
Accelrys Capture Drives Next-generation Mobility in the Laboratory
Mar 03, 2014, 13:08 ET
Accelrys Notebook 5.0 Sets New Standards for Moving from Paper-Based to Digital Laboratories
Feb 26, 2014, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.